 The Sage Group opens Israeli office with Appointment of Dr. Laurence Shaw as Executive Director
Date: 16 Dec 2009Cambridge UK and Clinton USA – December, 2009 – The Sage Group, Inc. is pleased to announce the expansion of its global network with the opening of an Israeli office and the appointment of Dr. Laurence Shaw as Executive Director. Dr. Shaw brings a breadth of additional experience and contacts in the healthcare and life science industry and financial sectors to Sage.
“We are very pleased that Laurence has joined Sage. Although Sage has been active in the Israeli life science and healthcare market for well over a decade, Dr. Shaw’s joining will significantly expand our capability and expertise in serving the strategic and transactional needs of Israeli companies .” said Wayne Pambianchi, Managing Director of Sage. “ We have for a long time admired the creative vitality of Israeli academic institutions, inventors and companies and with Dr. Shaw's strong healthcare and life science industry background, we shall be much better equipped to work more closely and with more Israeli entities on international transactions.”
Dr. Laurence Shaw, M.D. is the founder of Human Life Sciences, an international life science consulting practice that focuses on improving the productivity and profitability of Life Science companies. Dr. Shaw served as Corporate Vice President of Research and Development at C.R. Bard, Inc. At Abbott Laboratories, he was Vice President of Medical and Regulatory Affairs and Advanced Research. Previously, he was a board member of Revlon Health Care, Ltd. (UK) and Director of Medical and Technical Affairs. Dr. Shaw founded Atlantic Pharmaceuticals (now called Manhattan Pharmaceuticals), a public company, and was its CEO and President. Dr. Shaw was Chief Executive Officer and a director of Applied Spectral Imaging Ltd. Dr. Shaw also served as CEO and President of Pacific Pharmaceuticals, Inc. as well as Chairman of its board. Currently, Dr. Shaw is the Chairman of ConjuGate Ltd, and Biokine Therapeutics Ltd, acts as executive advisor to the Life Science Industry and sits on the board of several startup companies.
About The Sage Group, Inc. (WWW.SAGEHEALTHCARE.COM)
Sage is a leader in the provision of strategic and transactional advice to health care companies in the pharmaceutical, diagnostics, medical device, biotechnology and life science fields. Sage has operations in Clinton, NJ, Cambridge, England, and Yokohama, Japan. Since its founding in 1994, The Sage Group has served more than 200 clients in the US, Europe and Asia, and completed numerous transactions including divestitures, alliances, acquisitions and financings with values ranging from $5 million to $500 million. The establishment of operations in Europe and Japan and more recently Australia allows its clients to reach out beyond their own regions and capture the potential of the global healthcare market.
Sage is an organization of experienced and successful executives who are committed to the service of the very vital and dynamic health care industry and its investors.
The Sage Group's Principals, each an Executive Director, have been Founders, Chairmen, Presidents, CEO's and COO's of a number of emerging health care companies. These Principals have also held senior level management positions in large multi-national organizations.
The SAGE Group principals include:
Bill Mason-Founder of Life Science Resources, divested to Perkin Elmer; experience of a portfolio of private and public with experience of IPOs and VC funding with more than 50 healthcare transactions including divestment, M&A, licensing, funding, business development, strategic partnering.
Wayne Pambianchi-Co-founder of The Immune Response Corporation, Cortex Pharmaceuticals and Odyssey Nutriceutical Sciences; founder of The Medical Business Publishing Corporation
Gordon Ramseier-Previously, President and Chief Executive Officer of OncoTherapeutics; President and CEO of Immunetech Pharmaceuticals (Dura), Inc., Director of Marketing, Gynecological Products, at G.D. Searle.
Charles J. Casamento-Previously President & CEO of Osteologix, , Questcor, & RiboGene. Co-founder & CEO of Interneuron (Indevus). Vice President of Business Development and Strategic Planning for the Critical Care Division for and American Hospital Supply Corporation .Senior Vice President & General Manager Genzyme
R. Douglas Hulse- Previously President and Chief Operating Officer, Hemispherx BioPharma; Vice President, Business Development at Enzon, Inc.; Founder and Chief Executive Officer at i-STAT Corporation; Vice President of Engelhard Industries; Vice President and General Manager at Halcon International.
Daniel Tripodi Ph.D. Various senior positions at Johnson & Johnson.; Director of Technical Planning at Becton-Dickinson; General Manager of the Biomedical Division at New England Nuclear; Scientific Advisory Boards of the State University of New York at Stony Brook and the University of Utah; Trustee of Federal Trade Commission.
Yoshi Mizuta- Managing Director, Tsumura & Company; Vice President, Marketing and Sales, for Searle Yakuhin Company; Vice President, Business Development Japan for Monsanto/G.D. Searle; Business Development & licensing at Ono Pharmaceuticals.
The Sage Group can be contacted in Israel as shown below:
Dr H L Shaw
8 Heh Be'Iyar St
TEL AVIV 62093
ISRAEL
Tel: +972 (0)50-89-277-89
Fax: +972-3-695-2294
drhlshaw@hotmail.com |